243 related articles for article (PubMed ID: 20339486)
1. A review of the nonsurgical treatment of oral leukoplakia.
Ribeiro AS; Salles PR; da Silva TA; Mesquita RA
Int J Dent; 2010; 2010():186018. PubMed ID: 20339486
[TBL] [Abstract][Full Text] [Related]
2. Interventions for treating oral leukoplakia.
Lodi G; Sardella A; Bez C; Demarosi F; Carrassi A
Cochrane Database Syst Rev; 2006 Oct; (4):CD001829. PubMed ID: 17054142
[TBL] [Abstract][Full Text] [Related]
3. Interventions for treating oral leukoplakia.
Lodi G; Sardella A; Bez C; Demarosi F; Carrassi A
Cochrane Database Syst Rev; 2004; (3):CD001829. PubMed ID: 15266454
[TBL] [Abstract][Full Text] [Related]
4. Interventions for treating oral leukoplakia.
Lodi G; Sardella A; Bez C; Demarosi F; Carrassi A
Cochrane Database Syst Rev; 2001; (4):CD001829. PubMed ID: 11687126
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of randomized trials for the treatment of oral leukoplakia.
Lodi G; Sardella A; Bez C; Demarosi F; Carrassi A
J Dent Educ; 2002 Aug; 66(8):896-902. PubMed ID: 12214837
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention in oral leukoplakia: challenges and current landscape.
Palma VM; Koerich Laureano N; Frank LA; Rados PV; Visioli F
Front Oral Health; 2023; 4():1191347. PubMed ID: 37293562
[TBL] [Abstract][Full Text] [Related]
7. Although leukoplakia responds to some treatments relapses and adverse effects are common.
Lele S
Evid Based Dent; 2005; 6(1):15-6. PubMed ID: 15789045
[TBL] [Abstract][Full Text] [Related]
8. Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial.
Nagao T; Warnakulasuriya S; Nakamura T; Kato S; Yamamoto K; Fukano H; Suzuki K; Shimozato K; Hashimoto S
Int J Cancer; 2015 Apr; 136(7):1708-17. PubMed ID: 25156040
[TBL] [Abstract][Full Text] [Related]
9. Laser excision of oral leukoplakia: Does it affect recurrence and malignant transformation? A systematic review and meta-analysis.
de Pauli Paglioni M; Migliorati CA; Schausltz Pereira Faustino I; Linhares Almeida Mariz BA; Oliveira Corrêa Roza AL; Agustin Vargas P; Franco Paes Leme A; Bianca Brandão T; Prado Ribeiro AC; Ajudarte Lopes M; Santos-Silva AR
Oral Oncol; 2020 Jun; 109():104850. PubMed ID: 32540612
[TBL] [Abstract][Full Text] [Related]
10. A comparative study to evaluate the therapeutic effects of nutraceuticals in oral leukoplakia:- A randomized clinical trail.
Ahmad T; Khan I; Sultana A; Rizvi MMA
Natl J Maxillofac Surg; 2023; 14(3):413-419. PubMed ID: 38273920
[TBL] [Abstract][Full Text] [Related]
11. The combination of photodynamic therapy and fractional CO
Yao Y; Shen X; Shi L; Tang G; Wu L
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101597. PubMed ID: 31707101
[TBL] [Abstract][Full Text] [Related]
12. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study.
Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC
J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194
[TBL] [Abstract][Full Text] [Related]
13. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study.
Sundberg J; Korytowska M; Holmberg E; Bratel J; Wallström M; Kjellström E; Blomgren J; Kovács A; Öhman J; Sand L; Hirsch JM; Giglio D; Kjeller G; Hasséus B
PLoS One; 2019; 14(12):e0225682. PubMed ID: 31810078
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
[TBL] [Abstract][Full Text] [Related]
16. Marked variation in malignant transformation rates of oral leukoplakia.
Anderson A; Ishak N
Evid Based Dent; 2015 Dec; 16(4):102-3. PubMed ID: 26680515
[TBL] [Abstract][Full Text] [Related]
17. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
Chen HM; Yu CH; Tu PC; Yeh CY; Tsai T; Chiang CP
Lasers Surg Med; 2005 Aug; 37(2):114-22. PubMed ID: 16037967
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation of oral leukoplakia: a systematic review of observational studies.
Warnakulasuriya S; Ariyawardana A
J Oral Pathol Med; 2016 Mar; 45(3):155-66. PubMed ID: 26189354
[TBL] [Abstract][Full Text] [Related]
20. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
